Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography

scientific article

Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1084931885
P356DOI10.1186/S12886-017-0440-4
P932PMC publication ID5395976
P698PubMed publication ID28420348

P50authorChristopher Seungkyu LeeQ61117495
Sung Soo KimQ64104178
Hyoung Jun KohQ64104215
P2093author name stringSung Chul Lee
Ji Hwan Lee
Byunghoon Chung
P2860cites workA simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validationQ28285964
Contrast-induced nephropathyQ28293754
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationQ29547560
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupQ29614889
Prediction of creatinine clearance from serum creatinineQ29615603
Low incidence of side effects following intravenous fluorescein angiography.Q33173151
Contrast-induced nephropathy: definition, epidemiology, and patients at riskQ34566485
Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effectsQ36531491
Contrast medium use.Q36584089
Creatinine kinetics and the definition of acute kidney injuryQ37123296
Contrast-induced nephropathy and long-term adverse events: cause and effect?Q37258905
CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathyQ37304873
Contrast-induced acute kidney injuryQ37816785
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelinesQ37922124
Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?Q38077608
Contrast media viscosity versus osmolality in kidney injury: lessons from animal studiesQ38202647
Complications of intravenous fluorescein injectionsQ38255461
Evaluation of the side effects and image quality during fluorescein angiography comparing 2 mL and 5 mL sodium fluoresceinQ39861191
Failure to demonstrate contrast nephrotoxicityQ41161560
Adverse reactions to intravenous fluoresceinQ42096826
Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?Q43007224
Complications from fluorescein angiography: a prospective studyQ43249633
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.Q44260544
Measurement of change in estimated glomerular filtration rate in patients with renal insufficiency after contrast-enhanced computed tomography: a case-control study.Q45991548
Renal function following fluorescein angiography in diabetic patients with chronic kidney diseaseQ46107400
IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathyQ46113989
Renal function following infusion of radiologic contrast material. A prospective controlled studyQ48567420
Improving Outcomes from Acute Kidney InjuryQ61661823
Adverse reactions in intravenous fluorescein angiographyQ71136234
The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiencyQ73193150
A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast mediaQ80098929
Effect of fluorescein on renal function among diabetic patientsQ85017405
P433issue1
P921main subjectangiographyQ468414
contrast-induced nephropathyQ1783300
P304page(s)46
P577publication date2017-04-19
P1433published inBMC OphthalmologyQ15765692
P1476titleLower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography
P478volume17

Search more.